Understanding RSV: a significant threat for older adults this flu season ...

If you've had more than one friend cancel plans due to a nasty "stomach flu" or "stomach bug," they might actually have ...

Celiac Quebec (Cœliaque Québec) is co-organizing a first citizens' forum that will bring together patients, various ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

If you still haven't gotten your COVID or flu shot​, now is the time so you'll stay protected throughout the season, ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

A patient’s own blood could be used to help create a material potentially capable of repairing their broken bones, new ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

The Lice Treatment Global Market Report 2024 from ResearchAndMarkets.com reveals that there has been a 'global rise in the ...